Get all your news in one place.
100's of premium titles.
One app.
Start reading
Benzinga
Benzinga
Business
Alex Perry

Why Capricor Therapeutics Stock Is Surging Today

Gloves,,Test,And,Doctor,With,Medicine,,Syringe,Or,Preparing,Of

Shares of Capricor Therapeutics Inc. (NASDAQ: CAPR) are up Thursday after the company announced progress regarding one of its rare disease therapeutics. The biotech company’s stock jumped 18% immediately following the news.

What To Know: Capricor said it met with the U.S. Food and Drug Administration (FDA) to clarify the regulatory approval process for Deramiocel, the company’s investigational cell therapy for the treatment of Duchenne muscular dystrophy (DMD). The stock reached $7.32 on Thursday before pulling back a bit, according to Benzinga Pro.

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.